Basic info
Industry
biotechnology research
Sectors
Biotechnology
Therapeutics
Health Care
Medical
Date founded
2016
Funding rounds raised
Total raised
$150M
from 17 investors over 17 rounds
K
Kymera Therapeutics raised $150M on August 19, 2022
Investors: T. Rowe Price, Avoro Capital Advisors (formerly venBio Select Advisor) and Redmile Group
K
Kymera Therapeutics raised undisclosed on March 12, 2020
Investors: The Leukemia & Lymphoma Society
K
Kymera Therapeutics raised $102M on March 12, 2020
Investors: Solasta Ventures, Bessemer Venture Partners, Wellington Management, Vertex Pharmaceuticals and Redmile Group
K
Kymera Therapeutics raised $65M on November 13, 2018
Investors: 6 Dimensions Capital, Sanofi Ventures, Lilly Ventures, Bessemer Venture Partners, AJU IB INVESTMENT and Atlas Ventures
K
Kymera Therapeutics raised $30M on October 30, 2017
Investors: Lilly Ventures and Atlas Venture